TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY

This adverse event was reported 25 times

TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NARSOPLIMAB 1 0.0476
1 TAFASITAMAB-CXIX 1 0.0011
2 INOTUZUMAB OZOGAMICIN 2 0.0007
3 DEFLAZACORT 1 0.0004
4 MELPHALAN HYDROCHLORIDE 9 0.0004
5 URSOSIOL 7 0.0004
6 URSODIOL 7 0.0003
7 LETERMOVIR 1 0.0003
8 SIROLIMUS 4 0.0003
9 DEFIBROTIDE SODIUM 1 0.0003
See all drugs enriched for association with TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY